Three of these proteins—IL 12, TNFSF14, and CD244—have previously been considered as useful for clinical application in cancer therapy as promoters of tumor cell apoptosis, or as therapeutic targets [35,36,37]. Here, TNFSF14 is linked to neoplasm.